All News about Roche Holding AG Basel American Depositary Shares
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_127.png)
FDA Oncology Adcomm Votes To Keep Conditional Approval For Roche's Tecentriq In Place For Now
April 28, 2021
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_331.jpg)
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
April 28, 2021
Via Benzinga
Exposures
Product Safety
![](https://mms.businesswire.com/media/20210427006185/en/1024185/5/GENE_LOCKUP_Primary_FullColor_RGB.jpg)
![](https://images.pexels.com/photos/534216/pexels-photo-534216.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/laboratory-3827745_1920_38_0_4.jpg)
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
April 24, 2021
Via Benzinga
Exposures
Product Safety
![](https://g.foolcdn.com/editorial/images/622249/dna-sequence-genetics-test-genomics-2.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_92.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_329.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/ui-66_0.jpg)
![](https://cdn.pixabay.com/photo/2016/10/16/10/11/bullion-1744773_960_720.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_328.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_58.png)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_326.jpg)
![](https://mms.businesswire.com/media/20210415006150/en/1024185/5/GENE_LOCKUP_Primary_FullColor_RGB.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/test-214185_1280_88.jpg)
![](https://mms.businesswire.com/media/20210414006013/en/1024185/5/GENE_LOCKUP_Primary_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20210412005839/en/1024185/5/GENE_LOCKUP_Primary_FullColor_RGB.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/test-214185_1280_87.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_14.png)
![](https://mms.businesswire.com/media/20210407006051/en/1024185/5/GENE_LOCKUP_Primary_FullColor_RGB.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.